文献速递糖尿病肥胖与代谢综合征

通过糖尿病聚类检测肌少症风险:一项日本前瞻性队列研究

Detecting Sarcopenia Risk by Diabetes Clustering: A Japanese Prospective Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本研究为3年前瞻性队列研究,纳入659例日本1型或2型糖尿病患者,评估糖尿病聚类对肌少症发生的预测价值。结果显示,在5个糖尿病聚类中,严重自身免疫性糖尿病(SAID)和严重胰岛素缺乏性糖尿病(SIDD)聚类在校正已知风险因素后仍具有高肌少症发生风险。基于聚类的分层可能有助于预测和预防糖尿病患者肌少症。

要点

  • 日本糖尿病患者聚类分析得到5个聚类:SAID、SIDD、严重胰岛素抵抗性糖尿病、轻度肥胖相关糖尿病、轻度年龄相关糖尿病。
  • 基线时38例(6.5%)符合AWGS肌少症标准,3年内新发肌少症55例。
  • 校正已知风险因素后,SAID和SIDD聚类肌少症发生风险高。

核心结论

  • 在5个糖尿病聚类中,SAID和SIDD聚类发生肌少症的风险高。

研究设计与样本

  • 3年前瞻性队列研究,纳入2018年1月至2020年2月福岛糖尿病、内分泌与代谢队列中659例日本1型或2型糖尿病患者。

主要发现

  • 基线时38例(6.5%)符合AWGS 2019肌少症标准,3年内新发肌少症55例。
  • 校正已知风险因素后,SAID和SIDD聚类发生肌少症风险高。

关键数值与推荐

  • 肌少症诊断依据亚洲肌少症工作组(AWGS)2019共识更新。

临床怎么用

  • 基于聚类的分层可能有助于预测和预防糖尿病患者肌少症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Previous studies have assessed the usefulness of data-driven clustering for predicting complications in patients with diabetes mellitus. However, whether the diabetes clustering is useful in predicting sarcopenia remains unclear. OBJECTIVE: To evaluate the predictive power of diabetes clustering for the incidence of sarcopenia in a prospective Japanese cohort. DESIGN: Three-year prospective cohort study. SETTING AND PATIENTS: We recruited Japanese patients with type 1 or type 2 diabetes mellitus (n = 659) between January 2018 and February 2020 from the Fukushima Diabetes, Endocrinology, and Metabolism cohort. INTERVENTIONS: Kaplan-Meier and Cox proportional hazards models were used to measure the predictive values of the conventional and clustering-based classification of diabetes mellitus for the onset of sarcopenia. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia (AWGS) 2019 consensus update. MAIN OUTCOME MEASURES: Onset of sarcopenia. RESULTS: Cluster analysis of a Japanese population revealed 5 diabetes clusters: cluster 1 [severe autoimmune diabetes (SAID)], cluster 2 [severe insulin-deficient diabetes (SIDD)], cluster 3 (severe insulin-resistant diabetes, cluster 4 (mild obesity-related diabetes), and cluster 5 (mild age-related diabetes). At baseline, 38 (6.5%) patients met the AWGS sarcopenia criteria, and 55 had newly developed sarcopenia within 3 years. The SAID and SIDD clusters were at high risk of developing sarcopenia after correction for known risk factors. CONCLUSIONS: This study reveals that among the 5 diabetes clusters, the SAID and SIDD clusters are at a high risk for developing sarcopenia. Clustering-based stratification may be beneficial for predicting and preventing sarcopenia in patients with diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tanabe H, Hirai H, Saito H, et al. Detecting Sarcopenia Risk by Diabetes Clustering: A Japanese Prospective Cohort Study. J Clin Endocrinol Metab. 2022. PMID: 35908291. doi:10.1210/clinem/dgac430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。